Healios K.K Management
Management criteria checks 2/4
Healios K.K's CEO is Hardy Kagimoto, appointed in Feb 2012, has a tenure of 12.67 years. directly owns 31.88% of the company’s shares, worth $41.35M. The average tenure of the management team and the board of directors is 8.8 years and 6.8 years respectively.
Key information
Hardy Kagimoto
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 12.7yrs |
| CEO ownership | 31.9% |
| Management average tenure | 8.8yrs |
| Board average tenure | 6.8yrs |
Recent management updates
Recent updates
CEO
Hardy Kagimoto (48 yo)
12.7yrs
Tenure
Dr. Tadahisa S. Kagimoto, also known as Hardy, MD, serves as Chairman, Chief Executive Officer and President of Aqumen Biopharmaceuticals, K.K. He served as Director of Athersys, Inc. since June 18, 2018 u...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & CEO | 12.7yrs | no data | 31.88% ¥ 41.3m | |
| CFO, Executive Officer & Internal Director | 5.3yrs | no data | 0.21% ¥ 269.8k | |
| Executive VP | 9.6yrs | no data | no data | |
| Exec. Off. | 8.8yrs | no data | no data | |
| Managing Director | 8.6yrs | no data | no data |
8.8yrs
Average Tenure
48yo
Average Age
Experienced Management: HLOS.F's management team is seasoned and experienced (8.8 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & CEO | 12.7yrs | no data | 31.88% ¥ 41.3m | |
| CFO, Executive Officer & Internal Director | 6.8yrs | no data | 0.21% ¥ 269.8k | |
| Independent Outside Director | 2.8yrs | no data | no data | |
| Independent External Director | 6.8yrs | no data | 0.00022% ¥ 285.4 | |
| Auditor | 7.8yrs | no data | 0.56% ¥ 725.3k | |
| Independent Outside Director | 2.8yrs | no data | no data |
6.8yrs
Average Tenure
66.5yo
Average Age
Experienced Board: HLOS.F's board of directors are considered experienced (6.8 years average tenure).